Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
Worldwide revenue of $391.1 million and $1.53 billion for the fourth quarter and full year 2024Free cash flow was $141.4 million and $493.1 million for the fourth quarter and full year 2024GAAP fully ...
Optics21h
Evaluation of low-level light therapy assists Alzheimer's research
Low-level light therapy, also called photobiomodulation (PBM), has emerged as a promising approach to Alzheimer's treatment, ...
MedPage Today1d
For Your Patients: Navigating Treatment Options in Early Stage Alzheimer’s Disease
With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...
Alzheimer’S Therapeutics Market Poised For Growth: Projected To Surpass USD 10,433.9 Million By 2035 | Future Market Insights, Inc.
The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...
Scientific Research Publishing6d
BDNF Gene Therapy: A Potential Solution for Neurodegenerative Diseases ()
A Potential Solution for Neurodegenerative Diseases. Open Access Library Journal, 12, 1-16. doi: 10.4236/oalib.1112714 . Alzheimer’s Disease (AD), a complex neurodegenerative condition, significantly ...
New test could detect Alzheimer’s sign a decade before it shows up on brain scans
Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...